Abstract
A simple high performance liquid chromatographic (HPLC) method was developed for the determination of tolperisone in human plasma. Tolperisone and internal standard (chlorphenesin) were isolated from 1 mL of plasma using 8 mL of dichlormethane. The organic phase was collected and evaporated under nitrogen gas. The residue was then reconstituted with 300 mL aliquot of mobile phase and a 100 mL aliquot was injected onto the C18 reverse-phased column. The mobile phase, 45% methanol containing 1% glacial acetic acid and 0.05% 1-hexanesulfonic acid was run at a flow rate of 1 mL/min. The column effluent was monitored using UV detector at 260 nm. The retention times for tolperisone and the internal standard were approximately 7.1 and 8.4 min, respectively. The standard curve was linear with minimal intra-day and inter-day variability. The quantification limit of tolperisone in human plasma was 10 ng/mL. The proposed method has been applied to the determination of pharmacokinetic profile of tolperisone in Koreans. The Tmax of tolperisone in Koreans (0.94±0.42 h) was not significantly differ from that reported in Europeans (0.5–1 h), but the mean half-life in Koreans (1.14±0.27 h) was shorter than that in Europeans (2.56±0.2 h). The proposed HPLC method is simple, accurate, reproducible and suitable for pharmacokinetic study of tolperisone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bajaj, P., Arendt-Nielsen, L., Madeleine, P., and Svensson, P., Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force-a double-blind randomized crossover control study.Eur. J. Pain., 7, 407–418 (2003).
Fels, G., Tolperisone: evaluation of the lidocaine-like activity by molecular modelling.Arch. Pharm. Pharm. Med. Chem., 329, 171–178 (1996).
Kocsis, P., Tarnawa, I., Kovacs, G., and Szombathelyi, Z., Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD.Acta Pharm. Hung., 72, 49–61 (2002).
Liawruangrath, S., and Liawruangrath, B., High performance thin layer chromatographic determination of tolperisone hydrochloride.J. Pharm. Biomed. Anal., 20, 401–404 (1999).
Liawruangrath, S., Liawruangrath, B., and Pibool, P., Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography.J. Pharm. Biomed. Anal., 26, 865–872 (2001).
Miskolczi, P., Vereczkey, L., and Frenkl R., Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bio-availability studies.J. Pharm. Biomed. Anal., 5, 695–700 (1987).
Svensson, P., Wang, K., and Arendt-Nielsen, L., Effect of muscle relaxants on experimental jaw-muscle pain and jaw-stretch reflexes: a double-blind and placebo-controlled trial.Eur. J. Pain., 7, 449–456 (2003).
The Pharmacopoeia of Japan, 11th ed., pp. 1027 (1986).
The Pharmacopoeia of Japan, 12th ed., pp. 554 (1991).
Zsila, F., Holl-si, M., and Gergely, A., Stereochemical study of tolperisone, a muscle relaxant agent, by circular dichroism and ultraviolet spectroscopy.Chirality, 12, 720–726 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bae, JW., Park, YS., Sohn, UD. et al. HPLC Determination of tolperisone in human plasma. Arch Pharm Res 29, 339–342 (2006). https://doi.org/10.1007/BF02968581
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02968581